A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

Recruiting

Phase 2

Vaccine & Beta-glucanA Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma

Sponsor:

Memorial Sloan Kettering Cancer Center

Code:

NCT06057948

Conditions

Neuroblastoma

High-risk Neuroblastoma

Metastatic Neuroblastoma

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Interventions

OPT-821 (QS-21)

oral β-glucan

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-04-05. This information was provided to ClinicalTrials.gov by Memorial Sloan Kettering Cancer Center on 2026-04-02.